UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)
UvA-DARE (Digital Academic Repository)
Coagulation, angiogenesis and cancer
Niers, T.M.H.
Publication date
2008
Link to publication
Citation for published version (APA):
Niers, T. M. H. (2008). Coagulation, angiogenesis and cancer.
General rights
It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.
Contents
Chapter 1 General introduction 9.
Chapter 2 Mechanism of heparin induced anti-cancer activity in
experimental cancer models 23
Chapter 3 Validity of bioluminescence measurements for
noninvasive in vivo imaging of tumor load in small animals. 51
Chapter 4 The specificity of anticoagulants on cancer.
Do anticoagulants affect colon cancer? 69
Chapter 5 In vivo analysis of the antimetastatic effects of
anticoagulants on mouse cell lines B16, K1735 and CT26 83
Chapter 6 Experimental melanoma metastasis in lungs
of mice with congenital coagulation disorders. 99
Chapter 7 Metastasis promoting effects of thrombin inhibitors. 113 Chapter 8 Plasma cytokines and P-selectin plasma levels in advanced
malignancy: prognostic value and impact of low molecular
weight heparin administration. 127
Chapter 9 Prevention of catheter-related venous thrombosis with
nadroparin in patients receiving chemotherapy for hematological
malignancies, a randomized placebo controlled study. 143
Chapter 10 Circulating vascular endothelial growth factor in
cancer patients, is it a relevant biomarker? 159
Chapter 11 Kinetics of angiogenic biomarkers during
sorafenib treatment in patients with metastatic renal cell cancer 169
Summary 189 Samenvatting 193 Dankwoord 197
